Image

Aerobic Training Versus Behavioral Intervention to Increase Physical Activity in Patients With Asthma

Aerobic Training Versus Behavioral Intervention to Increase Physical Activity in Patients With Asthma

Recruiting
18-65 years
All
Phase N/A

Powered by AI

Overview

To compare the effects of aerobic training and behavioural intervention to increase physical activity in the clinical control of asthma and in the quality of life of patients with asthma.

Description

Adult participants of both genders with moderate to severe asthma, not physically active, will be evaluated after being informed about the study, agreeing and signing the informed consent form. Participants will be randomized to aerobic training or behavioral intervention group. Both interventions will consist of 8 weeks. Aerobic training will be performed on a treadmill (2xweek; 45 min/session). The behavioral intervention will be a program to increase physical activity (1xweek; up to 90 min / session). The maximum HR will be estimated according to the Tanaka's equation (208 - 0.7 x age).

Eligibility

Inclusion Criteria:

  1. Participants not physically active;
  2. Uncontrolled asthma (ACQ>1,5);
  3. Diagnosis of asthma based on the recommendations of the Global Initiative for Asthma (GINA 2020);
  4. Be under outpatient follow-up at the Pulmonology or Immunology service of the University of Sao Paulo General Hospital;
  5. Be under outpatient medical treatment for at least six months, with a stable clinical condition for at least 30 days;
  6. Being using optimized drug therapy for asthma.

Exclusion Criteria:

  1. Participation in another research protocol;
  2. Difficulty in understanding any of the questionnaires used;
  3. Practitioners of regular physical activity;
  4. Pregnancy and psychiatric problems that make it difficult to understand the questionnaires and the study protocol;
  5. Presence of another chronic lung, neurological or musculoskeletal disease that hinders or prevents physical activity;
  6. Patients who are smokers or ex-smokers (who have quit smoking for less than 1 year or who have smoked more than 15 pack-years).

Study details
    Asthma

NCT05364632

University of Sao Paulo General Hospital

23 May 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.